Phase
Condition
Spinal Cord Injuries
Treatment
Biostim-5/Neostim transcutaneous spinal stimulator
Clinical Study ID
Ages 3-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Chronic (> 1 year since injury), Acquired Upper motor Neuron injury (T10 and above)
Discharged from in-patient rehabilitation
Moderate to severe trunk control deficit as assessed by the Segmental Assessment ofTrunk Control (SATCo, score <16/20) OR unable to fully sit upright while liftingtheir arms or reaching outside of their base of support while maintaining posture
Novice to activity-based locomotor training and transcutaneous spinal stimulation
Exclusion
Exclusion Criteria:
Botox use within the past 3 months
Current oral baclofen use and unwillingness or unable to wean under medical guidance
Baclofen pump use
Musculoskeletal impairment limiting range of motion, unhealed fracture, or othermedical complication limiting participation
Prior surgery for scoliosis
Unwillingness to wean from the use of thoraco-lumbosacral orthosis (TLSO) duringstudy
Spina Bifida as etiology of spinal cord injury
Study Design
Study Description
Connect with a study center
Kentucky Spinal Cord Injury Res Center, University of Louisville
Louisville, Kentucky 40202
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.